Tesamorelin 10mg

Modified GHRH analog — 44 amino acids with N-terminal trans-3-hexenoic acid modification Lipophilic modification protects against aminopeptidase degradation in experimental models Research-grade · CAS 218949-48-5 For in vitro GHRH receptor research only

$72.99• In stock

Checkout through the store's WooCommerce payment and checkout settings.

▤Batch-specific test documentation is not currently linked to this product.

For laboratory research use only. Not for human or veterinary consumption. SKU TSM10.

Product details.

Specifications

Amino Acids	44
Modification	N-terminal trans-3-hexenoic acid
Molecular Weight	5135.83 g/mol
CAS Number	218949-48-5
Form	Lyophilized powder
Quantity	10mg per vial

Three ways to stabilize GHRH

Sermorelin: no modifications, short half-life (~11 min), clean pulsatile release. CJC-1295 No DAC: four amino acid substitutions, moderate half-life (30 min-2 hours). Tesamorelin: full-length sequence with lipophilic N-terminal cap. Three different engineering philosophies applied to the same receptor target. Heritage Labs USA stocks all three.

Research context

Protease assays have confirmed that the trans-3-hexenoic acid group provides effective aminopeptidase resistance. Published studies have examined Tesamorelin in pituitary GHRH receptor signaling, somatotroph response kinetics, and head-to-head comparisons with Sermorelin and CJC-1295.

Frequently paired with

Ipamorelin 10mg — Available as Ipa/Tesa Blend.

Storage

Lyophilized: -20°C
Reconstituted: 2-8°C, use within 30 days

For laboratory research use only. Not for human or veterinary use.

Technical reference adapted from the original Heritage Labs USA product listing. This description is not a certificate of analysis or evidence of testing for inventory supplied by this store.

For laboratory research use only. Not for human or veterinary consumption.